Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 0.06

Quantum-Si incorporated Debt to Equity Ratio is 0.06 for the Trailing 12 Months (TTM) ending September 30, 2024, a 17.16% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Quantum-Si incorporated Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.05.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
NasdaqGM: QSI

Quantum-Si incorporated

CEO Mr. Jeffrey Alan Hawkins
IPO Date Nov. 13, 2020
Location United States
Headquarters 530 Old Whitfield Street
Employees 159
Sector Healthcare
Industries
Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Similar companies

SEER

Seer, Inc.

USD 2.26

-5.44%

RNA

Avidity Biosciences, Inc.

USD 31.96

-2.95%

NRIX

Nurix Therapeutics, Inc.

USD 18.95

-3.86%

PRME

Prime Medicine, Inc.

USD 2.65

-5.36%

MNOV

MediciNova, Inc.

USD 1.94

-2.02%

VERV

Verve Therapeutics, Inc.

USD 7.52

-1.18%

HRTX

Heron Therapeutics, Inc.

USD 1.69

-0.59%

BDTX

Black Diamond Therapeutics, Inc.

USD 2.45

-6.49%

HOOK

HOOKIPA Pharma Inc.

USD 1.91

-2.55%

NTLA

Intellia Therapeutics, Inc.

USD 9.54

-7.56%

EDIT

Editas Medicine, Inc.

USD 1.27

-3.05%

BEAM

Beam Therapeutics Inc.

USD 25.59

-1.27%

CRBU

Caribou Biosciences, Inc.

USD 1.37

-4.20%

ALEC

Alector, Inc.

USD 1.64

-1.21%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.50

0.00%

CRSP

CRISPR Therapeutics AG

USD 41.59

-1.07%

StockViz Staff

February 4, 2025

Any question? Send us an email